The Gender Pain Gap - More than 50% of Women Say Their Pain Is Ignored by Doctors

Key Takeaways

• 53% of UK women say doctors ignore their pain.
• Dismissal rates rise to 73% among women aged 18‑24.
• 74% of Black women report pain dismissal, higher than White women.
• 21% of women turn to AI tools like ChatGPT for health advice.
• 46% become reluctant to seek medical help after dismissal.

Pulse Analysis

The latest Gender Pain Gap Index, released by Nurofen, quantifies a long‑standing disparity in how women’s pain is treated in the United Kingdom. More than half of surveyed women—53% overall and a striking 73% of those aged 18‑24—report that clinicians dismiss or ignore their symptoms. The gap widens along racial lines, with 74% of Black women and 65% of Asian women experiencing dismissal, compared with 51% of White women. Nearly all respondents (94%) say the neglect harms their wellbeing, eroding trust in the NHS and prompting a search for alternatives.

Faced with repeated dismissal, women are increasingly turning to unverified sources for answers. The index shows 74% have consulted non‑medical channels, and 21% have used AI chatbots such as ChatGPT to self‑diagnose. While AI can surface information quickly, it also amplifies the risk of misdiagnosis and exposure to misinformation, especially when users lack medical literacy. Policymakers have taken note: the Women and Equalities Committee warned that NHS reforms are not adequately prioritising women’s health, and the government’s new Women’s Health Strategy pledges to address medical misogyny.

Closing the gender pain gap will require coordinated action across the health system, technology providers, and employers. Training programs that teach clinicians to recognize bias, coupled with decision‑support tools that validate patient‑reported pain, can rebuild confidence. At the same time, responsible AI development—ensuring models are vetted by medical experts—offers a complementary safety net rather than a substitute for professional care. Advocacy groups like the Fawcett Society stress that policy must translate into measurable change, and initiatives such as Nurofen’s Pain Pass illustrate how data‑driven tools can empower women to be heard.